Hi Red....my mentality is that the new tests that are coming....the pinprick with almost instant results will be used in the coming months. They will have far greater accuracy than anything else and will be considered as the standard. Anything less from a results perspective may not get across the line because it will impact hospitals and front line health workers.
There is a lot of "If's" involved here...and I am not saying that Resapp should not be involved if they are asked to be....I am saying that shareholders should be satisfied that the company is progressing into Telehealth with Phenix and Coviu rapidly and they should concentrate on that. Resapp is not a big pharma that can throw 30 people at a problem and get a solution out quickly.
RAP Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
